Diversify your symposium or workshop! The ACS Committee on Minority Affairs Speakers Directory contains names, contact information, and expertise of chemists who are willing to give talks on a variety of topics. Click on the speaker’s name to see details about their expertise and background.
Dr. Mary Jo OndrechenProfessor Northeastern UniversityChemistry & Chemical Biology
Mary Jo Ondrechen received the Bachelor’s degree in Chemistry from Reed College and the Ph.D. degree in Chemistry and Chemical Physics from Northwestern University in Illinois. After postdoctoral research appointments at the University of Chicago and at Tel-Aviv University in Israel, the latter as a NATO Postdoctoral Fellow, she joined the faculty at Northeastern University in Boston, Massachusetts. Currently she is Professor of Chemistry and Chemical Biology. She is the Principal Investigator of the Computational Biology Research Group at Northeastern University. Her research deals with understanding enzyme catalysis, predicting the function of proteins, protein design, and the computational aspects of drug discovery. She is the past President of the Board of Directors of the North American Indian Center of Boston (NAICOB), has recently served on the Board of Advisers of the Interstate Technology and Regulatory Council, and was the 2011-2013 Chair of the Board of Directors of the American Indian Science and Engineering Society (AISES). She is a co-PI on the 2014-2019 project “Lighting the Pathway to Faculty Careers for Natives in STEM,” an initiative to provide guidance and support to Native STEM students who want to become faculty members at colleges, universities, and tribal colleges.
1. Electrostatic interactions and the multi-layered nature of enzyme active sites: Key features in natural and designed enzymes
2. Thinking outside the informatics box: Physical chemistry approach to functional genomics
3. Building opportunities on the path to faculty careers in higher education for Native Americans in STEM
4. Computers: Big guns in the development of new approaches to the treatment of disease